Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical and immunological studies of human fibroblast interferon.

Literature DB >> 6178525

Clinical and immunological studies of human fibroblast interferon.

K Ezaki, M Ogawa, K Okabe, K Abe, K Inoue, N Horikoshi, J Inagaki.

Abstract

Entities: Gene Species

Mesh：

Substances：
Interferons

Year: 1982 PMID： 6178525 DOI： 10.1007/BF00292871

Source DB: PubMed Journal: Cancer Chemother Pharmacol ISSN： 0344-5704 Impact factor: 3.333

× No keyword cloud information.

10 in total

1. Interferon therapy in Hodgkin's disease. A case report.

Authors: H Blomgren; K Cantell; B Johansson; C Lagergren; U Ringborg; H Strander
Journal: Acta Med Scand Date: 1976

2. Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.

Authors: T C Merigan; K Sikora; J H Breeden; R Levy; S A Rosenberg
Journal: N Engl J Med Date: 1978-12-28 Impact factor: 91.245

Review 3. Interferons: anti-neoplastic drugs?

Authors: H Strander
Journal: Blut Date: 1977-09-18

4. Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes.

Authors: P Lindahl; P Leary; I Gresser
Journal: Proc Natl Acad Sci U S A Date: 1972-03 Impact factor: 11.205

5. Positive correlation between in vitro NK activity and in vivo resistance towards AKR lymphoma cells.

Authors: I Riesenfeld; A Orn; M Gidlund; I Axberg; G V Alm; H Wigzell
Journal: Int J Cancer Date: 1980-03-15 Impact factor: 7.396

6. Interferon and spontaneous cytotoxicity in man. II. Studies in patients receiving exogenous leukocyte interferon.

Authors: S Einhorn; H Blomgren; H Strander
Journal: Acta Med Scand Date: 1978

7. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.

Authors: J U Gutterman; G R Blumenschein; R Alexanian; H Y Yap; A U Buzdar; F Cabanillas; G N Hortobagyi; E M Hersh; S L Rasmussen; M Harmon; M Kramer; S Pestka
Journal: Ann Intern Med Date: 1980-09 Impact factor: 25.391

8. Interferon therapy in myelomatosis.

Authors: H Mellstedt; A Ahre; M Björkholm; G Holm; B Johansson; H Strander
Journal: Lancet Date: 1979-02-03 Impact factor: 79.321

9. Induction and kinetics of natural killer cells in humans following interferon therapy.

Authors: J R Huddlestone; T C Merigan; M B Oldstone
Journal: Nature Date: 1979-11-22 Impact factor: 49.962

10. Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes.

Authors: F T Vánky; S A Argov; S A Einhorn; E Klein
Journal: J Exp Med Date: 1980-05-01 Impact factor: 14.307